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Abstract: We examined the procedures to combine two different in silico drug-screening results 
to achieve a high hit ratio. When the 3D structure of the target protein and some active compounds 
are known, both structure-based and ligand-based in silico screening methods can be applied. In 
the present study, the machine-learning score modiﬁ  cation multiple target screening (MSM-MTS) 
method was adopted as a structure-based screening method, and the machine-learning docking 
score index (ML-DSI) method was adopted as a ligand-based screening method. To combine 
the predicted compound’s sets by these two screening methods, we examined the product of the 
sets (consensus set) and the sum of the sets. As a result, the consensus set achieved a higher hit 
ratio than the sum of the sets and than either individual predicted set. In addition, the current 
combination was shown to be robust enough for the structural diversities both in different crystal 
structure and in snapshot structures during molecular dynamics simulations.
Keywords: in silico screening, consensus score, protein-based screening, protein-ligand docking, 
conformation of active site
Introduction
In silico drug screening results by structure-based screening methods strongly depend 
on the target protein’s 3D structure (Kontoyianni et al 2005; Warren et al 2006). Gen-
erally speaking, in silico screening succeeds in providing good database enrichment 
in approximately half of the cases, and it fails in hit compound prediction in another 
half of the cases. In some cases, the prediction results are much worse than the results 
obtained by random screening. In addition, even a slight structural change around the 
binding site will sometimes have a large effect on the docking scores (DeWeese-Scott 
and Moult 2004; Oshiro et al 2004). To overcome this problem, when several docking 
programs and scoring functions are available, consensus scoring methods are used 
(Charifson et al 1999; Wang and Wang 2001; Clark et al 2002; Wang and Wand 2003; 
Yang et al 2005; Oda et al 2006; Teramoto and Fukunishi 2007). The basic idea of the 
consensus score is to take the product of sets of two or more compound’s predicted by 
different scoring methods. Namely, the candidate hit compounds are the top scoring 
compounds common to two or more scoring functions (Charifson et al 1999). Several 
variations of the consensus scores have been proposed. For example, the ranking number 
of a compound is given by an average of the ranking numbers of two or more scoring 
functions (Wang and Wang 2001; Clark et al 2002; Wang and Wand 2003; Yang et al 
2005; Oda et al 2006; Teramoto and Fukunishi 2007). Instead of modifying the docking 
score, a combination of the quantitative structure-activity relationship (QSAR) method 
and the scoring function was also examined (Hetényi et al 2006).
In structure-based screening, the 3D structure of target protein must be known. There 
have been many reports about the relationship between target modeling methods and Advances and Applications in Bioinformatics and Chemistry 2008:1 20
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hit ratios (Bissantz et al 2003; Diller and Li 2003; McGovern 
and Shoichet 2003; DeWeese-Scott and Moult 2004; Oshiro 
et al 2004; Nicholls 2008; Sheridan 2008). Some reports 
have suggested that the hit ratios depend on the structure 
changes in the ligand-binding regions (DeWeese-Scott and 
Moult 2004; Oshiro et al 2004). McGovern and Shoichet 
(2003) have reported that the holo crystal structures would 
provide better enrichment than the apo crystal structures, 
and that the apo structures would provide better enrichment 
than the homology-modeled structures. However, the number 
of examples was small, and a more comprehensive study 
is needed to better our understanding of how to prepare 
the most suitable 3D-structure model for the target protein 
(Lerner et al 2007).
We have developed a protein-compound docking program 
and some in silico screening methods based on the protein-
compound afﬁ  nity matrix (Fukunishi et al 2005a, 2005b, 
2006a, 2006b, 2006c, 2006d, 2007). One screening method is 
a structure-based screening method called the multiple target 
screening (MTS) method (Fukunishi et al 2005b, 2006a), and 
the other is a ligand-based screening method called the dock-
ing score index (DSI) method (Fukunishi et al 2006b, 2006c, 
2006d, 2007). When the 3D structure of the target protein 
is known and some active compounds are known, we can 
apply both the structure-based and the ligand-based screening 
methods (Charifson et al 1999). A simple method to combine 
the results from these two methods is to take the sum of 
the two sets of predicted compounds. Another method 
is to take the consensus set (product of the two sets) of the 
predicted compounds. In the present study, we attempted to 
determine which method gives a better hit-ratio. In addition, we 
observed the robustness of these methods against the structural 
diversities, using several different crystal structures and snap-
shot structures during the molecular dynamics trajectories.
Our docking program, Sievgene, showed a standard accu-
racy in a self-docking test (Fukunishi et al 2005a), and the 
cross-docking results could be improved by the assistance of 
the known protein-compound complex structures by using the 
maximum volume overlap method (Fukunishi and Nakamura 
2008). Here, the dependence of screening performance on 
the target structure was examined.
Methods
Conventional screening (CS) method and 
protein-compound docking procedure
In the conventional screening (CS) method, compounds that 
show a strong afﬁ  nity with the target protein are selected 
by protein-compound docking software based on the 3D 
structure of the target protein.
In the present study, all protein-compound dockings were 
performed by our program, called Sievgene (Fukunishi et al 
2005a), which is a protein-ligand ﬂ  exible docking program 
for in silico drug screening. This program generates many 
conformers (default is up to 100 conformers) for each com-
pound, and keeps the target protein structure rigid but with 
soft interaction forces altering its structure to some extent 
(Fukunishi et al 2005a). Our docking program, Sievgene, is a 
part of the myPresto (prestoX) system, which is available, free 
for academic use, from the following website, http://presto.
protein.osaka-u.ac.jp/myPresto4/index_e.html.
Multiple target screening (MTS) method
In the present study, the MTS method was used to select the 
sum of the compound sets predicted by the multiple active 
site correction (MASC) scoring method and the original MTS 
method, as described previously (Fukunishi et al 2005b). The 
original version of the MTS method is based on a protein-
compound afﬁ  nity matrix, and the compounds that show 
strong afﬁ  nity with the target protein among many proteins 
are selected as candidate hit compounds.
First, let us brieﬂ  y explain the MTS method. We prepared 
a set of proteins P = {p1, p2, p3, …, pM}, where pa represents 
the a-th protein. The total number of proteins is M. We also 
prepared a set of compounds X = {x1, x2, …, xN}, where xi rep-
resents the i-th compound. The total number of compounds is 
N. For each protein pa, all compounds of set X are docked to 
protein pa with score sa
i between the a-th protein and the i-th 
compound. Here, sa
i corresponds to the binding free energy; 
a lower sa
i means a higher afﬁ  nity between the a-th protein 
and the i-th compound.
For the i-th compound, {sa
i; a = 1, …, M  } were sorted 
in descending order, and the order na
i assigned to each 
a-th protein depended on its value sa
i. For example, when 
na
i = 1, the a-th protein binds the i-th compound with the 
strongest afﬁ  nity. When na
i = M, the a-th protein binds with 
the weakest afﬁ  nity. This procedure was repeated until the 
order {na
i; a = 1, ..., M|i = 1, ..., N} was determined for 
all compounds. Next, we focus on the target a-th protein. 
The compounds having the order na
i = 1 are assigned as 
members in the compound group-1, compounds having 
na
i = 2 are assigned as members in compound group-2, and 
so on. Among the group-1 members, the compound with 
the lowest sa
i should be the most probable hit compound. 
If there is no compound in group-1, the compound with 
the lowest na
i in group-2 should be the most probable hit Advances and Applications in Bioinformatics and Chemistry 2008:1 21
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compound. This procedure is repeated until the most prob-
able hit compound is found. This procedure is the so-called 
MTS method.
The MASC score s’a
i for the a-th protein and the i-th 
compound has been reported by Vigers and Rizzi (2004) 
as follows:
  ss a
i
a
i
ii '( ) / , =− μσ  1
where sa
i is the raw docking score for the a-th protein and the 
i-th compound, and μi and σi are the average and standard 
deviation of the raw docking scores across all proteins for 
the i-th compound, respectively. In this method, s’a
i is used 
for screening instead of sa
i.
Both the MTS and the MASC scoring methods are applied 
in this study, and the combination of the results by these two 
methods (sum of sets) is taken as the set of candidate hit 
compounds. Namely, to get the top-ranked N compounds, the 
same numbers of compounds are tak6 MTS and the MASC 
scoring methods, and the sum of the two sets gives the total 
N compounds.
Direct score modiﬁ  cation (DSM) MTS 
method
In the DSM-MTS method, the score of a compound score on 
the a-th protein is a weighted average of the raw scores of 
that compound on proteins that are similar to the a-th protein. 
The DSM-MTS method modiﬁ  es the raw docking score as 
follows (Fukunishi et al 2006a):
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In the DSM-MTS method, the potential active compounds 
were selected by the MTS method through the DSM score 
instead of the original docking score.
Machine-learning score modiﬁ  cation 
(MSM) MTS method
In the MSM-MTS method, the score of a compound score 
on a protein is a weighted average of the raw scores of 
that compound on proteins and the weight is determined 
to maximize the hit ratio of the known active compounds. 
Equation 2 is rewritten as
 
ss M a
newi
b
i
a
b
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=∑   4
where sa
newi
, sb
i , and Ma
b are the new docking scores of the 
i-th compound with the a-th protein, the raw docking score of 
the i-th compound with the b-th protein, and the parameters, 
respectively.
If known active compounds are available, we can deter-
mine  Ma
b in eq. 4 to maximize the database enrichment 
(Fukunishi et al 2006a). Let x and f(x) be the numbers of 
compounds (%) selected from the total compound library 
and from the database enrichment curve, respectively. The 
surface area under the database enrichment curve (q) is a 
measure of the database enrichment.
 
qf x d x = ∫ ()
0
100
 5
Higher q values correspond to better database enrichment, 
and 0  q  100. The optimal Ma
b is determined by a Monte 
Carlo method to maximize the q value. The a-b element of the 
new matrix M (Mnew
a
b) is given by Mnew
a
b =  Ma
b + ηa
b; here, 
ηa
b is a random number. Using the newly generated matrix, 
the new docking score is calculated by eq. 4. Then an in silico 
screening method based on the new matrix M gives the q value 
by eq. 5. The best matrix M, which gives the highest q value, is 
selected as the seed matrix for the next optimization step. This 
process is repeated until the q value shows convergence.
Machine-learning docking score index 
(ML-DSI) method
The docking score index (DSI) method is a ligand-based 
screening method that utilizes molecular descriptors. The 
descriptors of compounds are docking scores with many pro-
teins, and compounds that are similar to active compounds are 
selected as candidate hit compounds. In the framework of the 
DSI method, a measure to represent the distance between two 
compounds is determined based on the protein-compound 
afﬁ  nity matrix. From the covariance matrix of the com-
pounds, principal component analysis (PCA) is performed 
to ﬁ  nd similar clusters of compounds. This DSI method has Advances and Applications in Bioinformatics and Chemistry 2008:1 22
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been described in detail in previous papers (Fukunishi et al 
2006b, 2007) and is brieﬂ  y introduced below.
We prepare a set of proteins P = {p1, p2, p3, …, pNr}, where 
pi represents the i-th protein and Nr the total number of 
proteins, and a set of compounds X = {x1, x2, …, xNc}, where 
xk represents the k-th compound and Nc the total number of 
compounds. For each protein pi, all compounds of the set X 
are docked to the protein pi with a score of si
k between the 
i-th protein and the k-th compound. Here, si
k corresponds to 
the binding free energy.
The covariance matrix MP of the proteins is deﬁ  ned as
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where the upper bar represents an average. Let φj be the j-th 
eigenvector of MP with an eigenvalue εj, and let the order of 
εj be descendant. The vector of docking scores for the k-th 
compound Xk = (s1
k, s2
k, …, sNr
k) is represented by the linear 
combination of φj
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The coefﬁ  cient {cj
k} represents the j-th coordinate of the 
PCA space of the k-th compound. In this study, we call this 
coefﬁ  cient {cj
k} the “docking score index (DSI)”.
Candidate hit compounds are selected using the following 
method. In the PCA space, compounds that are close to the 
known active compounds are selected as the candidate hit 
compounds. In the original version of the DSI method, the 
distance from the k-th compound to the average position of 
the active compounds (Dk) is deﬁ  ned as
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and
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where c  active
j and Na are the DSI values of the active 
compounds and the total number of active compounds. The 
sufﬁ  x j runs over the selected axes {α1, α2, …, αNselect}.
The principal component axes are selected in the follow-
ing manner. The contribution of each principal component 
is estimated using a database enrichment curve. The surface 
area under the database enrichment curve qα is evaluated 
for the α-th principal component axis; namely, the sufﬁ  x 
j in eq. 9 is set as α and Nselect is set as 1, and the database 
enrichment curve fα is calculated for the α-th axis, the same 
as in eq. 5. The qα values are calculated by
 
qf x d x αα = ∫ () ,
0
100
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where x and fα(x) are the percentages of compounds that are 
selected from the total compound library and the database 
enrichment curve, respectively.
The axes are sorted in descending order with respect to 
the qα value. The q value given by eq. 5 is a measure of the 
database enrichment in addition to qα in eq 11. The q value 
is calculated by changing the number of axes (Nselect) used 
in eq. 9 to ﬁ  nd the optimal Nselect value, which gives the 
maximum q value.
To apply the DSI method, the known active compounds 
must be available; hence, the docking score can be modiﬁ  ed 
to increase the database enrichment. If the new docking score 
is given by the linear combination of the docking scores with 
many proteins, as given by eq. 4, we can optimize the coef-
ﬁ  cients Ma
b to maximize the q value as in the MSM-MTS 
method. The MSM-MTS method is a QSAR method with 
machine learning. Many reports about the machine learning 
in ligand-based drug screening have been published and 
showed that the machine learning is very effective in drug 
screening (Anzali et al 1996; Livingstone 1996; Zupan and 
Gasteiger 1999; Burkard 2005; Plewczynski et al 2006; 
Ivanciuc 2007).
Materials
Protein set
Our screening methods are based on a protein-compound 
afﬁ  nity matrix. We therefore must prepare a set of proteins 
including target proteins. The set of proteins consisted of 
the 20 target proteins and a basic protein set of 150 proteins. 
The target protein structures were 20 protein structures of 
the human immunodeficiency virus protease-1 (HIVP), 
cyclooxygenase-2 (COX2), thermolysin (THR), and gluta-
thione S-transferase (GST) (Appendix A). Each protein has 
one apo structure. The complex structures of these target 
proteins include different ligands, and they show different 
binding modes.
For each target structure, an individual protein set was 
prepared. Each protein set consisted of a basic protein set and Advances and Applications in Bioinformatics and Chemistry 2008:1 23
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the target structure itself. All structures of the basic protein set 
were crystal structures. The target structures were prepared 
in two ways, as a crystal structure and as a ﬁ  nal snapshot 
structure generated by a molecular dynamics simulation. The 
preparation procedure is described in the next section.
The basic protein set was composed of 150 proteins, 
whose crystal structures of protein-ligand complexes are 
known (Appendix B). They were the same ones used to 
evaluate the docking programs, GOLD and FlexX (Nissink 
et al 2002), and they were also used in our previous works 
to evaluate our in silico screening program (Fukunishi et al 
2006a). The data set contains a rich variety of proteins and 
compounds whose structures were all determined by high-
quality experiments with a resolution of less than 2.5 Å. 
Almost all of the atom coordinates are supplied, except for 
those of the hydrogen atoms, and the all-atomic structures 
around the ligand proteins are quite reliable. In none of 
the complex structures are there any covalent interactions 
between the proteins and ligands.
Preparation of protein structures
Two types of protein models were prepared. The ﬁ  rst model 
(model A) is the original crystal structure, which includes 
the holo and apo crystal structure. The bound ligand, co-
activator, and water molecules were removed from the crystal 
structure. Lost hydrogen atoms were added to the protein 
structures without water and cofactors by using the program 
Tplgene in the myPresto suite (Fukunishi et al 2003, 2005a). 
The charges of protein atoms were originated from AMBER 
parm99 (Wang et al 2000; Case et al 2004).
The other model (model B) generated from the holo and 
apo crystal structure given by MD in explicit water was 
prepared as follows. The whole structure of each protein 
was embedded in a sphere of TIP3P (Jorgensen et al 1983; 
Jorgensen and Madura 1985) water (CAP water) including 
ion particles of 0.1% Na
+and Cl
_
 in order to neutralize the 
total charge of the systems. The center of the sphere was 
set at the mass center of the protein, and the radius was 
42, 52, 42, and 37 Å for HIVP, COX2, THR, and GST, 
respectively. Before performing MD calculations for the 
entire system, an MD calculation for only the solvent parts 
(solvent water and counter ions) was performed with the pro-
tein, ligand, and metal ions coordinates ﬁ  xed, so as to bring 
the solvent parts sufﬁ  ciently closer to an equilibrium state. 
MD simulations of the entire system were performed using 
0.5-fsec time steps with the temperature set at 310 K and the 
fast multipole method (Greengard and Rokhlin 1987) being 
used for calculation of the Coulombic interaction. The cut-off 
distance of the van der Waals interaction was 10.0 Å. The 
ﬁ  nal snapshot structures of holo and apo crystal structures 
at 500 psec simulations were used as model B. The MD 
simulations were performed by using the cosgene/myPresto 
(Fukunishi et al 2003).
Preparation of chemical compound 
libraries
The used compound library consisted of 110 known 
ligands for 20 target proteins, and 11,050 compounds of 
the Coelacanth chemical compound library (Coelacanth 
Corporation, East Windsor, NJ, USA), which is a random 
library, as a decoy set.
The 3D coordinates of 11,050 chemical compounds of the 
Coelacanth chemical compound library were generated by the 
Concord program (Tripos, St. Louis, MO, USA) from the 2D 
Sybyl SD ﬁ  les provided by the Coelacanth Chemical Corpora-
tion. The 3D coordinates of the known ligands were generated 
by the Chem3D program (Cambridge Software, Cambridge, 
MA, USA). The atomic charges of each compound in the 
compound library were determined by the Gasteiger method 
(Gasteiger and Marsili 1978; Gasteiger and Marsili 1980).
Results
The protein-compound afﬁ  nity matrixes were calculated for 
each target, and we then applied CS, MTS, DSM-MTS, MSM-
MTS, and ML-DSI methods. We took the consensus of the 
predicted compound’s sets by the MSM-MTS and ML-DSI 
methods and designated it as the “consensus set.” In contrast, 
we collected the sum of the predicted compound’s sets by the 
MSM-MTS and ML-DSI methods and called it the “sum set.” 
Protein models A and B were used as the crystal structures and 
the MD snapshot structures, respectively. Figure 1 shows the 
schematic representation of the screening procedure.
Table 1 shows the q values and hit ratios at the ﬁ  rst 1% 
of the entries in the database obtained by various screening 
methods for the 20 target proteins. Among these screening 
methods, the consensus set gave the best q value and the 
highest hit ratio for models A and B. The q value and the 
hit ratio for model A are close to the values for model B, 
respectively. In addition, the q value and hit ratio did not 
signiﬁ  cantly depend on differences in the target protein.
The sum set gave the second best q value among these 
screening methods. The hit ratio by the sum set was almost 
the average value of that by the MSM-MTS method and that 
by the ML-DSI method. Similar to with the consensus set, the 
q value and the hit ratio for model A was close to the values 
for model B. The q value and hit ratio did not signiﬁ  cantly Advances and Applications in Bioinformatics and Chemistry 2008:1 24
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depend on differences in the target protein. The q values 
obtained by the consensus set, the sum set, and the MSM-
MTS and ML-DSI methods were 89.6–98.6, 90.4–97.2, 
85.8–97.4, and 75.6–99.5, respectively.
Without known active compounds, we can apply the CS, 
MTS, and DSM-MTS methods. The MTS method gave the 
best q value, the DSM-MTS method gave the second best 
q value, and the CS method gave the worst q value among 
these three methods. In contrast, the CS method gave the 
best hit ratio, the DSM-MTS method gave the second best 
hit ratio, and the MTS method gave the worst hit ratio among 
these three methods. In general, the results obtained by the 
CS, MTS, and DSM-MTS methods strongly depended on 
the target structure model. These three methods gave good 
q values for HIVP. The MTS and DSM-MTS methods gave 
good q values for COX2, while the CS method gave poor q 
values for COX2. These three methods gave poor q values 
for THR and GST, with the DSM-MTS method giving the 
worst q values for GST.
Figure 2 shows the database enrichment curves obtained 
by the MSM-MTS method, the ML-DSI method, the con-
sensus set, and the sum set. The database enrichment curves 
by the consensus and sum sets were close to the database 
enrichment curve by the MSM-MTS method rather than 
that by the ML-DSI method. The database enrichment curve 
by the consensus set was the highest among these four 
curves in the range of the number of selected compounds 
20%. The database enrichment curve by the sum set was 
quite close to that by the consensus set. When the number 
of selected compounds was more than 20%, the sum set 
gave the highest database enrichment curve among these 
four curves.
The RMSD values between models A and B were approx-
imately 2 Å, and all values were less than 3 Å. The RMSD 
values of model B were approximately 1 Å bigger than those 
of model A. The q values of model B by the CS, the MTS and 
the DSM-MTS methods were much worse than the q values 
of model A. The result is consistent with the previous report 
(McGovern and Shoichet 2003). When active compounds are 
known for the target protein, the MSM-MTS and the ML-DSI 
methods are available. The q values by the MSM-MTS and 
the ML-DSI methods did not depend on the RMSD value 
or the difference in modeling methods. This result suggests 
that the MSM-MTS and ML-DSI methods are robust against 
Figure 1 Schematic representation of the screening methods in the current study. The same procedure was applied to models A and B. The protein set consists of the 
proteins listed in Appendixes A and B.Advances and Applications in Bioinformatics and Chemistry 2008:1 25
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the structure change on induced ﬁ  tting of the target protein 
as well as the consensus set and the sum set.
In all cases, the q values for apo structures were not as 
small as those for holo structures. In some cases, the q values 
for apo structures were better than the averaged q values. 
These results show that in silico screening could be applied 
to both apo and holo structures.
Discussion
Let us select the top-ranked N compounds by one method, 
which we will call “method 1” (in this study, the MSM-
MTS method) and the other top-ranked N compounds 
by another method, called “method 2” ( in this study, the 
ML-DSI method). Suppose that Na
1 active compounds 
are included in the N compounds by method 1, Na
2 active 
compounds are included in the N compounds by method 2, 
and Na active compounds are selected by both methods 1 
and 2. The number of inactive compounds by method 1 is 
N – Na
1 and that by method 2 is N – Na
2. Suppose that the 
number of inactive compounds selected by both methods 1 
and 2 is Ni. The hit ratio by the consensus set of compounds 
selected by methods 1 and 2 is Na /( Na + Ni), and the hit 
ratio by the sum set of compounds selected by methods 1 
and 2 is (Na
1 + Na
2 – Na)/(2N – Ni – Na). The hit ratio by the 
consensus set increases when Na increases or Ni decreases. 
The hit ratio by the sum set increases when Ni increases or 
Na decreases. For example, if N = 100, Na
1 = 36, Na
2 = 17, 
Na = 13, and Ni = 15, the hit ratio for model A in Table 1 
could be explained by these numbers. The results in Table 1 
suggest that the Na value is large and the Ni value is small. 
Thus the same active compounds should frequently be 
selected by both the MSM-MTS and the ML-DSI methods 
in the top-ranked compounds.
Klon and colleagues (2004a, 2004b, 2004c) have pro-
posed a combination of structure-based and ligand-based 
screening. In their method, the conventional structure-based 
screening was performed by a protein-compound docking 
program such as Glide, FlexX (Rarey et al 1996), or GOLD 
(Jones et al 1997). These three programs succeeded in ﬁ  nding 
the active compounds. The top-ranked compounds found by 
the structure-based screening were designated as candidate 
active compounds, while all other compounds were desig-
nated as candidate inactive compounds. The ﬁ  ngerprints 
were then calculated for all compounds in the database. 
A Bayesian model was trained using the ﬁ  ngerprints from 
the candidate active and inactive compounds. Finally, all of 
the compounds were re-ranked according to the Bayesian 
model. This method worked well and succeeded in increasing 
the hit ratio. This result suggests that the top-ranked active 
compounds by a structure-based screening have some 
common 2D descriptors (Klon et al 2004a, 2004b, 2004c). 
Thus the current consensus set of predicted compounds by 
structure-based and ligand-based screening should in general 
give a high hit ratio.
In the current study, the ML-DSI method was called 
the ligand-based screening method, while the target protein 
Figure 2 Database enrichment curves for models A and B. Filled circles, open circles, green squares, and red squares represent the results by the MSM-MTS method, the 
ML-DSI method, the sum sets of predicted compounds by the MSM-MTS and the ML-DSI methods, and the consensus sets of predicted compounds by the MSM-MTS and 
the ML-DSI methods, respectively. a: database enrichment curves for model A, in which the target protein structures are the original crystal structures. b: database enrichment 
curves for model B, in which the target protein structures are the model structures obtained by the MD simulations in explicit water.Advances and Applications in Bioinformatics and Chemistry 2008:1 27
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structure was used in the ML-DSI method. The DSI method 
is a kind of QSAR method, and the screening results by the 
DSI method do not strongly depend on the existence of the 
target structure in the used protein set (Fukunishi et al 2006a). 
It is also true for the ML-DSI method (Fukunishi et al 2006b). 
Thus, the ML-DSI method can be called as the ligand-based 
screening method.
In some cases, model B, which is a snap shot structure 
obtained by the MD, gave better hit ratio than model A, which 
is an energy-optimized crystal structure. The MD simulation 
gave the ligand-binding protein of slightly larger size than the 
energy-optimized crystal structure some times. The screening 
results obtained by the energy-minimized structures of apo 
proteins in vacuum were almost random screening results. 
The energy minimization in vacuum gave the ligand-binding 
protein of smaller size than the energy-optimized crystal 
structure of holo protein. The slightly large size protein can 
accept the active compounds, which are different from the 
ligand of the holo protein structure, while the small size 
protein cannot accept any active compound. That should 
be why model B could give the better results than model A 
in some cases.
Conclusion
We examined a method for combining the predicted 
compound sets obtained by structure-based and ligand-
based screenings. We found that the product of the two sets 
(consensus set) could give a better hit ratio than the individual 
hit ratios obtained by the structure-based and ligand-based 
screenings. The database enrichment by the sum of the two 
sets (sum set) was close to that obtained by the product of the 
two sets, but the hit ratio by the consensus set was higher than 
that by the sum set when less than 20% of the compounds of 
the database were selected.
For structure-based screening, an X-ray crystallography 
structure can give better results than a modeled structure 
given by a molecular dynamics simulation. When several 
active compounds are identiﬁ  ed, both the X-ray crystallogra-
phy structure and the MD structure can give a high hit ratio, 
and the hit ratios are robust against structural changes in the 
target protein such as induced ﬁ  tting. However, without any 
known active compounds, the results by the CS, MTS, and 
DSM-MTS methods strongly depend on structural changes 
of the target proteins.
We could not say which structure is better, the apo 
structure or holo structure, when Sievgene was used as docking 
software. Generally speaking, holo structures are more suitable 
for in silico screening and docking study than apo structures. 
In some cases, screening based on apo structures could provide 
better a hit ratio than that on holo structures.
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Appendix A
The protein databank (PDB) identiﬁ  er list of the target protein 
set is: the PDB codes of COX2’s crystal structures are 1cx2, 
1pxx, 4cox, 6cox, and 5cox; those of THR are 1tlp, 1tmn, 
2tmn, and 1l3f; those of HIVP are 1aid, 1hpx, 1ivp, 1htf1, 
1htf2, 4phv, and 3hvp; those of GST are 18gs, 2gss, 3pgt, and 
16gs. The apo forms are 5cox, 1l3f, 3hvp, and 16gs.
Appendix B
The protein databank (PDB) identiﬁ  er list of the basic protein 
set is: 1a28, 1a42, 1a4g, 1a4q, 1abe1, 1abe2, 1abf1, 1abf2, 
1aco, 1ai5, 1aoe, 1apt, 1apu, 1aqw, 1atl, 1b58, 1b9v, 1bma, 
1byb, 1byg, 1c1e, 1c5c, 1c83, 1cbs, 1cbx, 1cdg, 1ckp, 1com, 
1coy, 1cps, 1cvu, 1d0l, 1d3h, 1dd7, 1dg5, 1dhf, 1dog, 1dr1, 
1ebg, 1eed, 1ejn, 1epb, 1epo, 1ets, 1f0r, 1f0s, 1f3d, 1fen, 
1fkg, 1fki, 1ﬂ  3, 1glp, 1hdc, 1hfc, 1hos, 1hpv, 1hsb, 1hsl, 
1htf1, 1htf2, 1hyt, 1ida, 1ivb, 1jap, 1lah, 1lcp, 1lic, 1lna, 
1lst, 1mdr, 1mld, 1mmq, 1mrg, 1mts, 1mup, 1nco, 1ngp, 
1nis, 1okl, 1pbd, 1phd, 1phg, 1poc, 1ppc, 1pph, 1pso, 1qbr, 
1qbu, 1qpq, 1rds, 1rne, 1rnt, 1rob, 1snc, 1srj, 1tlp, 1tmn, 1tng, 
1tnh, 1tni, 1tnl, 1tyl, 1xid, 1xie, 1yee, 2aad, 2ack, 2ada, 2cht, 
2cmd, 2cpp, 2ctc, 2fox, 2gbp, 2ifb, 2pk4, 2qwk, 2tmn, 3cla, 
3cpa, 3erd, 3ert, 3tpi, 4lbd, 4phv, 5abp1, 5abp2, 5cpp, 5er1, 
6rnt, and 7tim. For 1abe, 1abf, 5abp, and 1htf, two protein 
proteins were prepared, since these proteins each bind two 
kinds of ligands.
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